View in EDS HTML Full Text PDF Full Text

Myeloid but not hepatocytic CD38 is a key driver for hepatic ischemia/reperfusion injury.

Saved in:
Bibliographic Details
Title: Myeloid but not hepatocytic CD38 is a key driver for hepatic ischemia/reperfusion injury.
Authors: Zhao QH; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.; School of Life Science, Nanchang University, Nanchang 330031, China., Zhang YT; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.; School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330031, China., Wen K; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.; School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330031, China., Ding Q; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China., Chen ZY; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.; School of Life Science, Nanchang University, Nanchang 330031, China., Tula D; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China., Li JH; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China., Zhou J; Department of Gynecology and Obstetrics, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China., Xiao YF; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China., Guan XH; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China., Deng KY; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China. dky@ncu.edu.cn.; School of Life Science, Nanchang University, Nanchang 330031, China. dky@ncu.edu.cn.; School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330031, China. dky@ncu.edu.cn., Wang LF; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China. wlfang1985@ncu.edu.cn., Xin HB; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China. xinhb@ncu.edu.cn.; School of Life Science, Nanchang University, Nanchang 330031, China. xinhb@ncu.edu.cn.; School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330031, China. xinhb@ncu.edu.cn.
Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2025 May 09; Vol. 10 (1), pp. 150. Date of Electronic Publication: 2025 May 09.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40341132
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Myeloid but not hepatocytic CD38 is a key driver for hepatic ischemia/reperfusion injury.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhao+QH%22">Zhao QH</searchLink>; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.; School of Life Science, Nanchang University, Nanchang 330031, China.<br /><searchLink fieldCode="AU" term="%22Zhang+YT%22">Zhang YT</searchLink>; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.; School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.<br /><searchLink fieldCode="AU" term="%22Wen+K%22">Wen K</searchLink>; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.; School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.<br /><searchLink fieldCode="AU" term="%22Ding+Q%22">Ding Q</searchLink>; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.<br /><searchLink fieldCode="AU" term="%22Chen+ZY%22">Chen ZY</searchLink>; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.; School of Life Science, Nanchang University, Nanchang 330031, China.<br /><searchLink fieldCode="AU" term="%22Tula+D%22">Tula D</searchLink>; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.<br /><searchLink fieldCode="AU" term="%22Li+JH%22">Li JH</searchLink>; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.<br /><searchLink fieldCode="AU" term="%22Zhou+J%22">Zhou J</searchLink>; Department of Gynecology and Obstetrics, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.<br /><searchLink fieldCode="AU" term="%22Xiao+YF%22">Xiao YF</searchLink>; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.<br /><searchLink fieldCode="AU" term="%22Guan+XH%22">Guan XH</searchLink>; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.<br /><searchLink fieldCode="AU" term="%22Deng+KY%22">Deng KY</searchLink>; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China. dky@ncu.edu.cn.; School of Life Science, Nanchang University, Nanchang 330031, China. dky@ncu.edu.cn.; School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330031, China. dky@ncu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Wang+LF%22">Wang LF</searchLink>; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China. wlfang1985@ncu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Xin+HB%22">Xin HB</searchLink>; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, Nanchang 330031, China. xinhb@ncu.edu.cn.; School of Life Science, Nanchang University, Nanchang 330031, China. xinhb@ncu.edu.cn.; School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330031, China. xinhb@ncu.edu.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101676423%22">Signal transduction and targeted therapy</searchLink> [Signal Transduct Target Ther] 2025 May 09; Vol. 10 (1), pp. 150. <i>Date of Electronic Publication: </i>2025 May 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101676423 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-3635 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220593635%22">20593635 </searchLink><i>NLM ISO Abbreviation: </i>Signal Transduct Target Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40341132
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41392-025-02233-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 150
    Titles:
      – TitleFull: Myeloid but not hepatocytic CD38 is a key driver for hepatic ischemia/reperfusion injury.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhao QH
      – PersonEntity:
          Name:
            NameFull: Zhang YT
      – PersonEntity:
          Name:
            NameFull: Wen K
      – PersonEntity:
          Name:
            NameFull: Ding Q
      – PersonEntity:
          Name:
            NameFull: Chen ZY
      – PersonEntity:
          Name:
            NameFull: Tula D
      – PersonEntity:
          Name:
            NameFull: Li JH
      – PersonEntity:
          Name:
            NameFull: Zhou J
      – PersonEntity:
          Name:
            NameFull: Xiao YF
      – PersonEntity:
          Name:
            NameFull: Guan XH
      – PersonEntity:
          Name:
            NameFull: Deng KY
      – PersonEntity:
          Name:
            NameFull: Wang LF
      – PersonEntity:
          Name:
            NameFull: Xin HB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 05
              Text: 2025 May 09
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2059-3635
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Signal transduction and targeted therapy
              Type: main
ResultId 1